已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy

医学 揭穿 剖腹手术 危险系数 围手术期 腹腔镜检查 外科 卵巢癌 置信区间 比例危险模型 阶段(地层学) 癌症 内科学 生物 古生物学
作者
Alexander Melamed,Roni Nitecki,David M. Boruta,Marcela G. del Carmen,Rachel M. Clark,Whitfield B. Growdon,Annekathryn Goodman,John O. Schorge,J. Alejandro Rauh‐Hain
出处
期刊:Obstetrics & Gynecology [Lippincott Williams & Wilkins]
卷期号:129 (5): 861-869 被引量:63
标识
DOI:10.1097/aog.0000000000001851
摘要

OBJECTIVE: To compare 3-year survival, length of hospitalization, perioperative mortality, risk of readmission, and residual disease associated with laparoscopic and laparotomic interval debulking surgery among women with epithelial ovarian cancer. METHODS: We used the National Cancer Database to identify a cohort of patients diagnosed with stage IIIC and IV epithelial ovarian cancer between 2010 and 2012 who underwent neoadjuvant chemotherapy and interval debulking surgery. We compared 3-year overall survival, duration of postoperative hospitalization, 90-day postoperative mortality, and residual disease status between women who underwent interval debulking by laparoscopy and by laparotomy. We used the Kaplan-Meier method and Cox regression models in survival analyses. At a significance of .05, this study had 80% power to detect an 8% difference in 3-year survival. The main analysis was intention to treat. RESULTS: We identified 3,071 women meeting inclusion criteria, of whom 450 (15%) underwent surgery initiated laparoscopically. There was no difference in 3-year survival between patients undergoing laparoscopy [47.5%; 95% confidence interval (CI) 41.4–53.5] and laparotomy (52.6%; 95% CI 50.3–55.0; P =.12). Survival did not differ after adjustment for demographic characteristics, facility type, presence of comorbidities, and stage (adjusted hazard ratio, 1.09; 95% CI 0.93–1.28; P =.26). Postoperative hospitalization was slightly shorter in the laparoscopy group (median 4 compared with 5 days, P <.001). Frequency of readmission (5.3% compared with 3.7%; P =.26), death within 90 days of surgery (2.8% compared with 2.9%, P =.93), and suboptimal debulking (20.6% compared with 22.6%, P =.29) did not differ between patients undergoing laparoscopy and laparotomy. CONCLUSION: Ovarian cancer patients selected for laparoscopic interval debulking surgery after neoadjuvant chemotherapy have 3-year survival rates similar to women who undergo interval debulking by laparotomy. Laparoscopy is associated with a modestly shorter postoperative hospitalization, whereas readmission rates and risk of perioperative death are similar for the surgeries.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英姑应助zhou采纳,获得10
刚刚
Lynn发布了新的文献求助10
刚刚
Lynn发布了新的文献求助10
刚刚
Lynn发布了新的文献求助10
1秒前
christinas发布了新的文献求助10
3秒前
心宇完成签到,获得积分10
4秒前
Yangshu发布了新的文献求助10
4秒前
4秒前
orixero应助哭泣的访天采纳,获得10
4秒前
医学完成签到,获得积分10
4秒前
5秒前
只想摸鱼发布了新的文献求助10
7秒前
7秒前
柔三皿发布了新的文献求助10
10秒前
zhangfue1989完成签到 ,获得积分10
11秒前
小芮完成签到,获得积分10
11秒前
13秒前
北瑾完成签到,获得积分20
13秒前
尚先生完成签到 ,获得积分10
14秒前
15秒前
15秒前
Hello应助白斯特采纳,获得10
18秒前
七里香完成签到,获得积分10
19秒前
19秒前
Yangshu发布了新的文献求助10
19秒前
20秒前
一叶知秋完成签到 ,获得积分10
21秒前
tingwaiwufengyu完成签到 ,获得积分10
23秒前
wyx发布了新的文献求助15
23秒前
24秒前
天天快乐应助科研通管家采纳,获得10
24秒前
搜集达人应助科研通管家采纳,获得10
24秒前
Jun完成签到 ,获得积分10
24秒前
科研通AI2S应助科研通管家采纳,获得10
24秒前
CodeCraft应助科研通管家采纳,获得10
24秒前
顾矜应助科研通管家采纳,获得10
25秒前
25秒前
25秒前
心宇发布了新的文献求助10
25秒前
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
核安全综合知识2024版 500
Photothermal Science and Techniques 500
Digital Displacement Hydrostatic Transmission for Rotorcraft and Distributed Propulsion 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7705493
求助须知:如何正确求助?哪些是违规求助? 9263142
关于积分的说明 20041733
捐赠科研通 7281122
什么是DOI,文献DOI怎么找? 3295304
关于科研通互助平台的介绍 2450288
邀请新用户注册赠送积分活动 2302172